Hongmei Chen
Impact in
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery
-
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
Papers in
- Immunology 11
- Immunotherapy and Immune Responses 4
- Phagocytosis and Immune Regulation 3
- Immune cells in cancer 2
-
- Nanoplatforms for cancer theranostics 7
- Co-authors
- Tianmeng Sun (9 shared papers)Jialiang Wang (8 shared papers)Yong‐Guang Yang (8 shared papers)Xiuxiu Cong (8 shared papers)Chenxi Wu (7 shared papers)Kuirong Mao (7 shared papers)Xiandi Meng (4 shared papers)Martin W. Feyereisen (1 shared paper)
- Journals
- Biomaterials (4 papers)Biomaterials Science (3 papers)Advanced Theory and Simulations (1 paper)BioMed Research International (1 paper)Archives of Virology (1 paper)
- Partner nations
- ChinaUnited StatesCroatia
In The Last Decade
Hongmei Chen
30 papers receiving 757 citations
Peers
Comparison fields: 5 of 100
- Biomaterials 134
- Immunology 169
- Cancer Research 63
- Biomedical Engineering 198
- Oncology 91
Countries citing papers authored by Hongmei Chen
This map shows the geographic impact of Hongmei Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hongmei Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hongmei Chen more than expected).
Fields of papers citing papers by Hongmei Chen
This network shows the impact of papers produced by Hongmei Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hongmei Chen. The network helps show where Hongmei Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Hongmei Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 102 | |
| 2 | 2006 | 76 | |
| 3 | 2020 | 73 | |
| 4 | 2020 | 72 | |
| 5 | 1993 | 55 | |
| 6 | Investigation of Microencapsulated BSH Active Lactobacillus in the Simulated Human Gl Tract | 2007 | 50 |
| 7 | 2017 | 40 | |
| 8 | 2020 | 39 | |
| 9 | 2019 | 31 | |
| 10 | 2013 | 26 | |
| 11 | 2023 | 25 | |
| 12 | 2021 | 21 | |
| 13 | 2021 | 19 | |
| 14 | 2018 | 17 | |
| 15 | 2015 | 14 | |
| 16 | 2010 | 13 | |
| 17 | 2018 | 13 | |
| 18 | 2017 | 12 | |
| 19 | 2022 | 11 | |
| 20 | 2018 | 10 |
About Hongmei Chen
Hongmei Chen is a scholar working on Immunology, Biomedical Engineering, Materials Chemistry, Molecular Biology and Nutrition and Dietetics, having authored 31 papers that have together received 760 indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (7 papers), Immunotherapy and Immune Responses (4 papers), NF-κB Signaling Pathways (4 papers), RNA Interference and Gene Delivery (3 papers), Microbial infections and disease research (3 papers), Nanoparticle-Based Drug Delivery (3 papers), Phagocytosis and Immune Regulation (3 papers) and Immune cells in cancer (2 papers). The work is most often cited by research in Biomaterials (134 citations), Immunology (169 citations), Cancer Research (63 citations), Biomedical Engineering (198 citations) and Oncology (91 citations). Hongmei Chen has collaborated with scholars based in China, United States and Croatia. Frequent co-authors include Tianmeng Sun, Jialiang Wang, Yong‐Guang Yang, Xiuxiu Cong, Chenxi Wu, Kuirong Mao, Xiandi Meng, Martin W. Feyereisen, George Fitzgerald and Sailaja Ghanta. Their work appears in journals such as Biomaterials, Biomaterials Science, Advanced Theory and Simulations, BioMed Research International and Archives of Virology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.